Journals / Mikrobiyoloji Bülteni / 2004 / Cilt: 38 - Sayı: 3

Case report: A Fusarium fungaemia

Olgu raporu: Bir Fusarium fungemisi

Pages
265–271
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, Fusarium infections which manifest with fungaemia and fever as the only symptoms, should be taken into consideration in neutropenic patients receiving immunosuppressive therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this report, a case of Fusarium fungaemia developed in an acute lymphoblastic leukemia (ALL) patient was presented.
📊
Key Findings & Data:A seven year old girl who had weakness, loss of appetite, paleness and ecchymosis on legs applied to Pediatric Hematology Service and cytotoxic chemotherapy was started after she had been diagnosed as ALL-L1.
💡
Conclusion & Impact:In conclusion, Fusarium infections which manifest with fungaemia and fever as the only symptoms, should be taken into consideration in neutropenic patients receiving immunosuppressive therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fusarium · Lösemi · lenfositik

Abstract

In this report, a case of Fusarium fungaemia developed in an acute lymphoblastic leukemia (ALL) patient was presented. A seven year old girl who had weakness, loss of appetite, paleness and ecchymosis on legs applied to Pediatric Hematology Service and cytotoxic chemotherapy was started after she had been diagnosed as ALL-L1. Her chemotherapy was stopped because of increase in fever, leukopenia and neutropenia. Central venous catheter and peripheral blood cultures were obtained. Fusarium thapsinum was recovered from blood cultures, obtained in two consecutive days. Thereupon central venous catheter of the patient was removed and intravenous amphotericin B was added to the therapy. On the fifth day of febrile neutropenia attack, her fever was decreased after the onset of antifungal therapy. Radiological examinations were normal and no fungal growth was observed in the later blood cultures. On the 21st day of amphotericin B therapy, chemotherapy was started again and amphotericin B was changed to peroral itraconazole (200 mg/day) at the fifth week. The patient whose itraconazole therapy was stopped after three months, was still in remission and continued receiving her prolonged therapy. In conclusion, Fusarium infections which manifest with fungaemia and fever as the only symptoms, should be taken into consideration in neutropenic patients receiving immunosuppressive therapy.

Özet

Bu raporda, akut lenfoblastik lösemili (ALL) bir hastada gelişen Fusarium fungemisi olgusu sunulmaktadır. Halsizlik, iştahsızlık, solukluk ve bacaklarında morluklar nedeniyle başvurduğu Çocuk Hastalıkları Hematoloji Kliniğinde ALL-L1 tanısı alan yedi yaşındaki kız hastaya kemoterapi başlanmıştır. Yoğun sitotoksik kemoterapi alırken, ateşinin yükselmesi, lökopenik ve nötropenik olması üzerine hastanın kemoterapisi kesilmiş ve santral venöz kateter ile periferik kan kültürleri alınmıştır. İki gün üst üste alınan kan kültür örneklerinde Fusarium thapsinum üremesi saptanmıştır. Bunun üzerine hastanın santral venöz kateteri çıkartılmış ve amfoterisin B tedaviye eklenmiştir. Bu uygulama ile febril nötropenir atağının beşinci gününde hastanın ateşi normale dönmüştür. Radyolojik incelemeleri normal olarak değerlendirilen olgunun daha sonraki kan kültürlerinde üreme olmamıştır. Amfoterisin B tedavisinin 21. gününde kemoterapiye tekrar başlanmış ve amfoterisin B beşinci haftada kesilerek, oral itrakonazole (200 mg/I gün) geçilmiştir, itrakonazol tedavisi üç ay sonra kesilen hasta halen remisyonda olup, idame tedavi almaya devam etmektedir. Sonuç olarak, olgumuzda da izlendiği gibi erken tanı ve tedavinin hayati önem taşıdığı immünosüpresif hastalarda, ateş dışında başka bir bulgunun olmadığı, sadece fungemi ile seyreden Fusarium enfeksiyonlarına dikkat edilmelidir.

🔖

Cite This Article

YÜCESOY, M., ERGUN, M. C., ÖREN, H., GÜLAY, Z. (2004). Case report: A Fusarium fungaemia. Mikrobiyoloji Bülteni, Cilt: 38 - Sayı: 3, 265–271. https://ajindex.com/articles/299652

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Sigler L, Verwij PE: Aspergillus, Fusarium and other opportunistic moniliaceous fungi, p: 1726-1760. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (eds), Manual of Clinical Microbiology. 2003, 8th ed Amer Soc Microb, Washington DC
  2. Hospenthal DR, Bennett JE: Miscellaneous fungi and Prototheca, p: 2772-2780. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Pennsylvania
  3. De Pauw BE, Donnelly JP: Infections in the immunocompromised host: General principles, p: 3079-3090. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed Churchill Livingstone, Pennsylvania
  4. Vartivarian SE, Anaissie EJ, Bodey GP: Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis and management Clin Infect Dis 1993, 17 (Suppl 2): S487-S491 5. Perfect JR, Schell WA: The new fungal opportunists are coming Clin Infect Dis 1996, 22 (Suppl 2): S112-S118 6 Fleming RV, Walsh TJ, Anaissie EJ: Emerging and less common fungal pathogens. Infect Dis Clin N Am 2002, 16: 915-933
  5. Larone DH: Hyaline Hyphomycetes, p: 255-289. In Medically Important Fungi: A Guide to Identification. 2002, 4th ed. Amer Soc Microb, Washington DC. 8. de Hoog GS, Guarro J, Gene J, Fıgueras MJ: Atlas of Clinical Fungi, p; 681-705 2000, 2nd ed. Centraalbureau woor Schimmelcultures, Utrecht, Netherlands
  6. National Comittee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P 1997, NCCLS, Wayne. Philadelphia
  7. Ener B: Nadir görülen fırsatçı mikozlar, s: 1105-1109. Mutlu G, İmir T, Cengiz T, Ustaçelebi Ş, Tumbay E, Mete Ö (ed), Temel ve Klinik Mikrobiyoloji. 1999, Güneş Kitabevi, Ankara
  8. Yıldıran ŞT, Kömürcü S, Saraçlı MA, et al: Fusarium fungaemia in severely neutropenic patients. Mycoses 1998, 41: 467-469
  9. Segal BH, Walsh TJ, Liu JM, Wilson JD, Kwong-Chung KJ: Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia J Clin Microbiol 1998, 36: 1772-1776
  10. Nirenberg HI, O'Donnel K: New Fusarium species and combinations within the Gibberella fujikuroi species complex. Mycologia 1998, 90: 434-458
  11. Guarro J, Gene J: Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995, 14: 741-754 15. Perfect JR New therapies for rare and refractory fungal infections. 13lh Europe